Immatics inks $920M licensing deal with Bristol Myers Squibb
Immatics, which develops a pipeline of cancer therapies, has an administrative office and a research laboratory in Houston.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Chris Mathews Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Health Management | Laboratory Medicine